Form 4 for STE Steris
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0001209191-22-034157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-03 | 2022-06-01 | STE | Madsen Julia | Senior VP, Life Sciences | F - Tax | $221.46 | -42 | 6,198 | -0.7% | -$9,301 |
| D | 2022-06-03 | 2022-06-02 | STE | Madsen Julia | Senior VP, Life Sciences | A - Grant | $0.00 | +1,408 | 7,606 | +23% | $0 |
| D | 2022-06-03 | 2022-06-02 | STE | Madsen Julia | Senior VP, Life Sciences | A - Grant | $0.00 | +6,404 | 6,404 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-06-01 | F | D | 42 | $221.46 | 6,198 | D | — | — | (F1) 42 shares were withheld from the 123 restricted shares that vested on June 1, 2022. These 42 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. (F2) As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. |
| 2 | Common | Ordinary Shares | 2022-06-02 | A | A | 1,408 | $0.00 | 7,606 | D | — | — | (F2) As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. |
| 3 | Derivative | Employee Stock Options (right to buy) | 2022-06-02 | A | A | 6,404 | $0.00 | 6,404 | D | $250.06 · — to 2032-06-02 | 6,404 Ordinary Shares | (F3) This option becomes exercisable as follows: 1,601 on June 2, 2023, 1,601 on June 3, 2024, 1,601 on June 2, 2025 and 1,601 on June 2, 2026 |